Tokushima University to Collaborate with SOCIUM Inc. Strategic partnership aims to AI-driven drug discovery for Rare Gastrointestinal Tumor

SOCIUM Inc. announced that SOCIUM Inc. (Head office: Chuo-ku, Tokyo, CEO: Dr. Hiroshi Kawai) has entered into a joint research agreement with Tokushima University Graduate School of Biomedical Sciences (Tetsuji Takayama, Professor, Department of Gastroenterology and Oncology) regarding AI-driven Drug Discovery for Gastrointestinal Tumor.

Click here for details (PDF).